During the past decade, SUNY Stony Brook NICHD CRS (5040) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SUNY Stony Brook NICHD CRS (5040)" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "SUNY Stony Brook NICHD CRS (5040)" are "HIV Disease" (1 trials), "HIV Infection" (1 trials), "HIV Infections" (1 trials) and "HIV-1 Infection" (1 trials). Many other conditions were trialed in "SUNY Stony Brook NICHD CRS (5040)" in a lesser frequency.

Most popular intervention types in "SUNY Stony Brook NICHD CRS (5040)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "3TC or FTC monotherapy" (1 trials), "Atazanavir" (1 trials), "Atazanavir (ATV)" (1 trials), "Darunavir" (1 trials) and "Darunavir (DRV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "SUNY Stony Brook NICHD CRS (5040)" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "SUNY Stony Brook NICHD CRS (5040)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SUNY Stony Brook NICHD CRS (5040), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SUNY Stony Brook NICHD CRS (5040), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".